journal article·2017-02

The impact of cell surface PEGylation and short-course immunotherapy on islet graft survival in an allogeneic murine model

Jaime A. Giraldo, R. Damaris Molano, Hernán R. Rengifo, Carmen Fotino, Kerim M. Gattás-Asfura, Antonello Pileggi, Cherie L. Stabler

Acta Biomaterialia· Volume 49
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Pancreatic function and diabetes · Diabetes and associated disorders · Diabetes Management and Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (79)

Show source-provided references
1. Beta-cell death during progression to diabetes10.1038/414792a ↗
2. Future trends in islet cell transplantation10.1089/15209150050194314 ↗
3. International trial of the Edmonton protocol for islet transplantation10.1056/NEJMoa061267 ↗
4. Improved long-term health-related quality of life after islet transplantation10.1097/TP.0b013e31818a7f45 ↗
5. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation10.1097/TP.0b013e318166a27b ↗
6. Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia10.2337/dc15-1988 ↗
7. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia10.2337/diabetes.51.1.66 ↗
8. Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver10.2337/diabetes.53.4.948 ↗
9. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation10.2337/diabetes.51.6.1779 ↗
10. Allosensitization of islet allograft recipients10.1097/01.tp.0000290388.70019.6e ↗
11. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation10.1111/j.1600-6143.2008.02479.x ↗
12. Alloreactive (CD4-Independent) CD8+ T cells jeopardize long-term survival of intrahepatic islet allografts10.1111/j.1600-6143.2008.02219.x ↗
13. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity10.1210/jc.2007-0172 ↗
14. Enhancing clinical islet transplantation through tissue engineeering strategies10.1177/193229681000400525 ↗
15. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islet allografts10.1097/00007890-199610150-00004 ↗
16. Effect of hypoxia on insulin secretion by isolated rat and canine islets of Langerhans10.2337/diab.42.1.12 ↗
17. Emulsion strategies in the microencapsulation of cells: pathways to thin coherent membranes10.1002/bit.20597 ↗
18. Microfluidic-based generation of size-controlled, biofunctionalized synthetic polymer microgels for cell encapsulation10.1002/adma.201304880 ↗
19. Device design and materials optimization of conformal coating for islets of Langerhans10.1073/pnas.1402216111 ↗
20. Bioorthogonal layer-by-layer encapsulation of pancreatic islets via hyperbranched polymers10.1021/am401981g ↗
21. Long-term survival of allograft murine islets coated via covalently stabilized polymers10.1002/adhm.201300573 ↗
22. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase10.1016/S0021-9258(17)40292-4 ↗
23. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol10.1016/S0021-9258(17)40291-2 ↗
24. Chemical camouflage of antigenic determinants: stealth erythrocytes10.1073/pnas.94.14.7566 ↗
25. Treatment of rat pancreatic islets with reactive PEG10.1016/S0142-9612(99)00283-5 ↗
26. Optimization of monomethoxy-polyethylene glycol grafting on the pancreatic islet capsules10.1002/jbm.10246 ↗
27. Immunocamouflage: the biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mPEG)10.1016/j.actbio.2010.01.031 ↗
28. Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication10.1089/ten.2006.0009 ↗
29. Immuno-isolation of pancreatic islet allografts using pegylated nanotherapy leads to long-term normoglycemia in full MHC mismatch recipient mice10.1371/journal.pone.0050265 ↗
30. Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet10.1111/j.1600-6143.2006.01414.x ↗
31. A combination therapy of PEGylation and immunosuppressive agent for successful islet transplantation10.1016/j.jconrel.2005.10.023 ↗
32. LFA-1 (CD11a) as a therapeutic target10.1111/j.1600-6143.2005.01158.x ↗
33. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-410.4049/jimmunol.164.7.3627 ↗
34. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice10.1097/01.TP.0000092525.17025.D0 ↗
35. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection10.1385/IJGC:26:1:23 ↗
36. Blockade of leukocyte function antigen-1 (LFA-1) in clinical islet transplantation10.1007/s11892-011-0214-y ↗
37. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways10.4049/jimmunol.169.9.4831 ↗
38. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation10.2337/diabetes.50.9.1983 ↗
39. Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials10.1073/pnas.1113560109 ↗
40. Experimental evaluation and computational modeling of the effects of encapsulation on the time-profile of glucose-stimulated insulin release of pancreatic islets10.1186/s12938-015-0021-9 ↗
41. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound10.2337/diabetes.51.8.2561 ↗
42. Prolonged islet allograft survival in diabetic nod mice by targeting CD45RB and CD15410.2337/diabetes.52.4.957 ↗
43. LFA-1-specific therapy prolongs allograft survival in rhesus macaques10.1172/JCI43895 ↗
44. Macrophage polarization in response to ECM coated polypropylene mesh10.1016/j.biomaterials.2014.04.115 ↗
45. Analyzing real-time PCR data by the comparative C(T) method10.1038/nprot.2008.73 ↗
46. Characterization of integrin expression in islets isolated from hamster, canine, porcine, and human pancreas10.1177/002215549904700408 ↗
47. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol)10.1182/blood.V93.6.2121.406a30_2121_2127 ↗
48. A tripartite anoikis-like mechanism causes early isolated islet apoptosis10.1067/msy.2001.116413 ↗
49. Reactive coupling of poly(ethylene glycol) on electroactive polyaniline films for reduction in protein adsorption and platelet adhesion10.1016/S0142-9612(01)00184-3 ↗
50. Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces10.1016/j.biomaterials.2004.03.036 ↗
51. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-γ or IL-410.4049/jimmunol.164.7.3627 ↗
52. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival10.1111/j.1600-6143.2004.00384.x ↗
53. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival10.1097/01.TP.0000085010.39567.FB ↗
54. Cyclosporine: a review10.1155/2012/230386 ↗
55. Combined costimulatory and leukocyte functional antigen-1 blockade prevents transplant rejection mediated by heterologous immune memory alloresponses10.1097/TP.0b013e31824e75d7 ↗
56. Translating costimulation blockade to the clinic: lessons learned from three pathways10.1111/j.1600-065X.2009.00776.x ↗
57. Effect of culture on islet rejection10.2337/diab.29.1.S93 ↗
58. Lymphocyte antigenicity loss with retention of responsiveness10.1126/science.184.4135.464 ↗
59. Prolonged allogeneic islet graft survival by protoporphyrins10.3727/000000005783983160 ↗
60. Anti-inflammatory strategies to enhance islet engraftment and survival10.1007/s11892-013-0401-0 ↗
61. Islet inflammation: a unifying target for diabetes treatment?10.1016/j.tem.2013.01.007 ↗
62. Anakinra and tocilizumab enhance survival and function of human islets during culture: implications for clinical islet transplantation10.3727/096368913X667529 ↗
63. Concise review: new insights into the role of macrophages in beta-cell proliferation10.5966/sctm.2014-0248 ↗
64. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass10.2337/diab.43.6.778 ↗
65. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation10.2337/diabetes.47.3.316 ↗
66. Targeting co-stimulatory pathways: transplantation and autoimmunity10.1038/nrneph.2013.183 ↗
67. Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection10.2337/db12-0242 ↗
68. Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction10.1111/ajt.13098 ↗
69. M.H. Oberbarnscheidt, Q. Zeng, Q. Li, H. Dai, A.L. Williams, W.D. Shlomchik, D.M. Rothstein, F.G. Lakkis, Non-self recognition by monocytes initiates allograft rejection, J Clin Invest 124(8): 3579–3589.10.1172/JCI74370 ↗
70. Cell-permeable peptide blocks TLR4 signaling and improves islet allograft survival10.3727/096368916X690449 ↗
71. F.O. Martinez, S. Gordon, The M1 and M2 paradigm of macrophage activation: time for reassessment, F1000Prime Rep 6 (2014).10.12703/P6-13 ↗
72. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes10.1016/S1471-4906(02)02302-5 ↗
73. Human anti-inflammatory macrophages induce Foxp3+GITR+CD25+ regulatory t cells, which suppress via membrane-bound TGFβ-110.4049/jimmunol.181.3.2220 ↗
74. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation10.4049/jimmunol.182.1.148 ↗
75. Cd4+Cd25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade10.1084/jem.193.11.1311 ↗
76. National institutes of health-sponsored clinical islet transplantation consortium phase 3 trial: manufacture of a complex cellular product at eight processing facilities10.2337/db16-0234 ↗
77. Encapsulation of islets with ultra-thin polyion complex membrane through poly(ethylene glycol)-phospholipids anchored to cell membrane10.1016/j.biomaterials.2006.07.039 ↗
78. Ultrathin polymeric coatings based on hydrogen-bonded polyphenol for protection of pancreatic islet cells10.1002/adfm.201200138 ↗
79. Noncovalent cell surface engineering with cationic graft copolymers10.1021/ja908887v ↗